Men's Health News

RSS

Study provides comprehensive analysis of economic burden in cancer survivors

A new study finds the economic burden of cancer extends beyond diagnosis and treatment, and concludes that cancer survivors face thousands of dollars of excess medical expenses every year as well as excess employment disability and loss of production at work.

14 May 2015

Prostate cancer patients who receive androgen deprivation therapy may experience cognitive problems

Cognitive impairment can occur in cancer patients who are treated with a variety of therapies, including radiation therapy, hormone therapy, and chemotherapy. After chemotherapy treatment it is commonly called "chemo brain." Signs of cognitive impairment include forgetfulness, inability to concentrate, problems recalling information, trouble multi-tasking and becoming slower at processing information.

13 May 2015

WHO Press Release: World Health Statistics reports on global health goals for 194 countries

Progress in child survival worldwide is one of the greatest success stories of international development. Since 1990, child deaths have almost halved – falling from an estimated 90 deaths per 1000 live births to 46 deaths per 1000 live births in 2013...

13 May 2015

Managing cancer at work: Johns Hopkins launches new service for all employees

Johns Hopkins Medicine has created and launched Managing Cancer at Work, a new and novel health benefit program offered free of charge for its more than 42,000 combined full-time equivalent employees.

12 May 2015

Research finds link between oestrogen levels and male breast cancer

Men with naturally high levels of the female hormone oestrogen may have a greater risk of developing breast cancer, according to research by an international collaboration including Cancer Research UK published today in the Journal of Clinical Oncology.

12 May 2015

1 in 10 patients harmed while in hospital - Addressing the big problem?

It is now widely accepted that 1 in 10 patients admitted to hospital will be unintentionally harmed in some way. This harm can be caused by a range of errors or adverse events...

From Isansys Lifecare Ltd. 12 May 2015

World renowned surgeon evaluates parallels between Prostate cancer, Breast cancer

World renowned robotic prostate cancer surgeon, Dr. David Samadi, evaluates the parallels between Prostate cancer and Breast cancer. Prostate cancer is just as common in men as breast cancer is in women with over 233,000 cases diagnosed each year.

12 May 2015

Experimental gene therapy holds promise against metastatic prostate cancer

Even with the best available treatments, the median survival of patients with metastatic, hormone-refractory prostate cancer is only two to three years. Driven by the need for more effective therapies for these patients, researchers at VCU Massey Cancer Center and the VCU Institute of Molecular Medicine have developed a unique approach that uses microscopic gas bubbles to deliver directly to the cancer a viral gene therapy in combination with an experimental drug that targets a specific gene driving the cancer's growth.

12 May 2015

Raising lupus awareness: an interview with Professor Ramsey-Goldman, MD

Lupus is a chronic, autoimmune disease, with many different symptoms so it is hard to diagnose. It affects each person differently and it has an unpredictable disease course with flare ups and quiet time. Some patients describe lupus as if they are riding a roller coaster with blinders on because they cannot always tell when they will feel well or sick...

11 May 2015

The future of cancer treatment set to be transformed through the opening of new Cancer Institute

NHS patients will soon benefit from the opening of a new cancer centre specialising in the use of diagnostics for targeted cancer medicines used to treat some of the UK’s most common cancers...

11 May 2015

A pioneering facial recognition cane for the blind

The ‘XploR’ mobility cane, being developed by ICT students Steve Adigbo, Waheed Rafiq and Richard Howlett, uses smartphone technology to recognise familiar faces from up to 10m away. The cane also features GPS functionality to aid navigation...

11 May 2015

Moffitt scientists examine why prostate cancer patients who receive ADT experience hot flashes

Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after treatment. Moffitt Cancer Center researchers are working to determine what genetic factors and other characteristics might make prostate cancer patients more likely to experience hot flashes during and after therapy.

10 May 2015

Cholesterol-lowering statin drugs could delay prostate cancer growth in patients receiving ADT

Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn't take statins, a clinical trial led by Dana-Farber Cancer Institute investigators shows.

8 May 2015

WHO committed to helping Nepal deliver health care to its citizens, says WHO South-East Asia Regional Director

The World Health Organization is committed to supporting Nepal’s health system to deliver life-saving and essential services to its people and build back resilient health facilities that will be safe in emergencies...

7 May 2015

Transition Therapeutics acquires worldwide rights from Lilly to develop, commercialize TT701

Transition Therapeutics Inc. today announced its wholly-owned subsidiary, Transition Therapeutics Ireland Limited, has exclusively licensed worldwide rights to a novel small molecule drug candidate ("TT701") from Eli Lilly and Company.

6 May 2015

Weston Park Hospital offers two cutting-edge treatments for rare cancer tumours, prostate cancer

TWO cutting-edge cancer treatments using targeted radioactive therapy injections to destroy cancer cells are now being offered to patients with rare neuroendocrine tumours and patients with prostate cancer at Weston Park Hospital.

6 May 2015

Study shows that periodontal treatment can reduce symptoms of prostatitis

Treating gum disease reduced symptoms of prostate inflammation, called prostatitis, report researchers from Case Western Reserve University School of Dental Medicine and the Departments of Urology and Pathology at University Hospitals Case Medical Center.

6 May 2015

Kallistem achieves complete human spermatogenesis in vitro for treatment of male infertility

Kallistem, which develops innovative cell culture technologies in reproductive biology, today announces a world first: human spermatogenesis in vitro. At the end of 2014 the company was able to produce fully formed human spermatozoa in the laboratory setting, using patient testicular biopsies containing only immature germ cells, or spermatogonia.

5 May 2015

Novel Ga-68-PSMA-ligand PET/CT effective for early detection of prostate cancer recurrence

A recent study reported in The Journal of Nuclear Medicine compared use of the novel Ga-68-PSMA-ligand PET/CT with other imaging methods and found that it had substantially higher detection rates of prostate-specific membrane antigen (PSMA) in patients with biochemical recurrence after radical prostatectomy.

5 May 2015

Life expectancy is on the rise in England and Wales, but more so for some than others

In England and Wales, life expectancy is projected to reach 85.7 years for men and 87.6 years for women by 2030, according to findings published in The Lancet...

1 May 2015

Men's Health News

Study provides comprehensive analysis of economic burden in cancer survivors

Prostate cancer patients who receive androgen deprivation therapy may experience cognitive problems

WHO Press Release: World Health Statistics reports on global health goals for 194 countries

Managing cancer at work: Johns Hopkins launches new service for all employees

Research finds link between oestrogen levels and male breast cancer

1 in 10 patients harmed while in hospital - Addressing the big problem?

World renowned surgeon evaluates parallels between Prostate cancer, Breast cancer

Experimental gene therapy holds promise against metastatic prostate cancer

Raising lupus awareness: an interview with Professor Ramsey-Goldman, MD

The future of cancer treatment set to be transformed through the opening of new Cancer Institute

A pioneering facial recognition cane for the blind

Moffitt scientists examine why prostate cancer patients who receive ADT experience hot flashes

Cholesterol-lowering statin drugs could delay prostate cancer growth in patients receiving ADT

WHO committed to helping Nepal deliver health care to its citizens, says WHO South-East Asia Regional Director

Transition Therapeutics acquires worldwide rights from Lilly to develop, commercialize TT701

Weston Park Hospital offers two cutting-edge treatments for rare cancer tumours, prostate cancer

Study shows that periodontal treatment can reduce symptoms of prostatitis

Kallistem achieves complete human spermatogenesis in vitro for treatment of male infertility

Novel Ga-68-PSMA-ligand PET/CT effective for early detection of prostate cancer recurrence

Life expectancy is on the rise in England and Wales, but more so for some than others

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News